These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25407510)

  • 21. Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D- and L-cysteine at positions i and i+3, respectively, derived from HIV-1 gp41 C-peptide.
    Lee MK; Kim HK; Lee TY; Hahm KS; Kim KL
    Exp Mol Med; 2006 Feb; 38(1):18-26. PubMed ID: 16520549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Old plants newly discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts inhibit in vitro HIV-1c replication in peripheral blood mononuclear cells (PBMCs) by different modes of action.
    Leteane MM; Ngwenya BN; Muzila M; Namushe A; Mwinga J; Musonda R; Moyo S; Mengestu YB; Abegaz BM; Andrae-Marobela K
    J Ethnopharmacol; 2012 May; 141(1):48-56. PubMed ID: 22326358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.
    Mills KH; Kitchin PA; Mahon BP; Barnard AL; Adams SE; Kingsman SM; Kingsman AJ
    J Immunol; 1990 Mar; 144(5):1677-83. PubMed ID: 1689753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysine oligopeptide method for human immunodeficiency virus infection.
    Okuda K; Kaneko T; Yamakawa T; Tanaka S; Shigematsu T; Yamamoto A; Hamajima K; Nakajima K; Kawamoto S; Phanuphak P
    J Mol Recognit; 1993 Sep; 6(3):101-9. PubMed ID: 8060667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of synthetic peptides for the detection of antibodies against human immunodeficiency virus].
    Lottersberger J; Salvetti JL; Tonarelli G
    Rev Argent Microbiol; 2003; 35(3):149-55. PubMed ID: 14587377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
    Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA
    Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.
    Jiang S; Debnath AK
    Biochem Biophys Res Commun; 2000 Apr; 270(1):153-7. PubMed ID: 10733920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
    Kazmierski WM; Kenakin TP; Gudmundsson KS
    Chem Biol Drug Des; 2006 Jan; 67(1):13-26. PubMed ID: 16492145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tubeimoside-1 on HIV core protein p24 and cytopathogenesis in vitro.
    Yu LJ; Ma RD; Jiang SB
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):103-6. PubMed ID: 8010099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR4-derived synthetic peptides inducing anti-HIV-1 antibodies.
    Hashimoto C; Nomura W; Narumi T; Fujino M; Nakahara T; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2013 Nov; 21(22):6878-85. PubMed ID: 24119449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
    Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A
    Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combined cheminformatics and computational approach for the prediction of anti-HIV small molecules.
    Poorinmohammad N; Mohabatkar H
    Curr Comput Aided Drug Des; 2014; 10(4):349-53. PubMed ID: 25994640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-HIV activity of ADS-J1 targets the HIV-1 gp120.
    Armand-Ugón M; Clotet-Codina I; Tintori C; Manetti F; Clotet B; Botta M; Esté JA
    Virology; 2005 Dec; 343(1):141-9. PubMed ID: 16168454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.
    Wang C; Shi W; Cai L; Lu L; Yu F; Wang Q; Jiang X; Xu X; Wang K; Xu L; Jiang S; Liu K
    J Antimicrob Chemother; 2014 Jun; 69(6):1537-45. PubMed ID: 24500189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular recognition in the human immunodeficiency virus capsid and antiviral design.
    Bocanegra R; Rodríguez-Huete A; Fuertes MÁ; Del Álamo M; Mateu MG
    Virus Res; 2012 Nov; 169(2):388-410. PubMed ID: 22728445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro inhibition of R5 HIV-1 infectivity by X4 V3-derived synthetic peptides.
    Baritaki S; Dittmar MT; Spandidos DA; Krambovitis E
    Int J Mol Med; 2005 Aug; 16(2):333-6. PubMed ID: 16012771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HIV-1 peptides derived from partial amino acid sequences of CC-chemokine RANTES. Regulated upon activation, normal T-cell expressed and secreted.
    Nishiyama Y; Murakami T; Shikama S; Kurita K; Yamamoto N
    Bioorg Med Chem; 2002 Dec; 10(12):4113-7. PubMed ID: 12413865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of metalloproteinase family based on the concept of Chou's pseudo amino acid composition using a machine learning approach.
    Mohammad Beigi M; Behjati M; Mohabatkar H
    J Struct Funct Genomics; 2011 Dec; 12(4):191-7. PubMed ID: 22143437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.